Wait, don't miss out on the latest GovCon industry news!

Sign Up Now! GovCon Wire provides you with Daily Updates and News Briefings

*By clicking "Join us now" you agree to receive email, promotions and general messages from GovCon Wire, In addition, you also agree to GovCon Wire Privacy Policy and Terms & Conditions.

X Remind me Later

DLA Awards Mylan Pharmaceuticals $121M Lidocaine Patch Supply Contract

medical health doctorMylan Pharmaceuticals (Nasdaq: MYL) has won a potential $121.5 million contract from the Defense Logistics Agency to provide lidocaine 5 percent patch, a medicine designed for the treatment of post-herpetic neuralgia pain.

Mylan will supply the medical product to the departments of Defense and Veterans Affairs as well as the Indian Health Services and Federal Bureau of Prisons under the firm-fixed-price contract,  DoD said Tuesday.

DoD noted the contract has one base year and four option years.

The company will perform work in West Virginia, Vermont and North Carolina through Sept. 12, 2021.

DLA Troop Support received four proposals for the contract and will obligate defense working capital funds in fiscal year 2017 through fiscal 2021.

GovCon Wire Logo

Sign Up Now! GovCon Wire provides you with Daily Updates and News Briefings about Contract Awards

Related Articles